Inhaled colistin for the treatment of multidrug-resistant gram-negative bacilli lower respiratory tract infections: a retrospective chart review
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: LIANG, Shin-Yi (E-Da Hospital, Pharmacy, Kaohsiung, China Taiwan)
- Co-author(s): Shin-Yi Linag:|Li-Ching Chien:|Yi-Ping Hsiang:
In emerging multidrug-resistant (MDR) Acinetobacter and Pseudomonas pulmonary infections, colistin has been the last line of effective antibiotics. Data support inhaled colistin as a new effective adjuvant treatment for MDR gram-negative bacilli ventilator associated pneumonia. Few studies evaluated the efficacy of inhaled colistin only with.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.